loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 103172 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ALTEPLASE (3)

filter

01 GENENTECH (3)

filter

01 VIAL (1)

02 VIAL; SINGLE-USE (2)

filter

01 100MG/VIAL (1)

02 2MG/VIAL (1)

03 50MG/VIAL (1)

filter

01 USA (3)

URL Supplier Web Content
VIAL
2MG/VIAL
CATHFLO ACTIVASE
USA
103172
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
VIAL; SINGLE-USE
100MG/VIAL
ACTIVASE
USA
103172
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
VIAL; SINGLE-USE
50MG/VIAL
ACTIVASE
USA
103172
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 103172

Looking for CTD TGA MCC DOSSIER APPLICATION 103172 3

19

Genentech, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ALTEPLASE, with a corresponding application number 103172 and regulatory information .

proudly manufactured in the

Genentech's CATHFLO ACTIVASE VIAL, medication with 2MG/VIAL of ALTEPLASE.

18

Genentech, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ALTEPLASE, with a corresponding application number 103172 and regulatory information .

proudly manufactured in the

Genentech's ACTIVASE VIAL; SINGLE-USE, medication with 100MG/VIAL of ALTEPLASE.

17

Genentech, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ALTEPLASE, with a corresponding application number 103172 and regulatory information .

proudly manufactured in the

Genentech's ACTIVASE VIAL; SINGLE-USE, medication with 50MG/VIAL of ALTEPLASE.

Post Enquiry
POST ENQUIRY